That said, two primary AML samples also had SF3B1 mutation, one PSAT1-negative and auxotrophic and the other PSAT1-positive and NA (Figure 8), further illustrating the primacy of PSAT1 in determining serine auxotrophy in AML. This evidence concerns the gene SF3B1 and acute myeloid leukemia.